StockClub

FDMT

FDMT4D Molecular Therapeutics, Inc.$ --
4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.

FDMT

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
85M USD
YoY +8508900.0%
Operating Income
15M USD
YoY +126.2%
Net Income
19M USD
YoY +139.1%
EPS
0.34$
YoY +137.8%

Revenue

$85.2M
FY2024 Q1$28,000
$28,000
Q1
FY2024 Q2$33,000
$33,000
Q2
FY2024 Q3$36,000
$36,000
Q3
FY2024 Q4$37,000
$37,000
Q4
FY2025 Q1$14,000
$14,000
Q1
FY2025 Q2$29,000
$29,000
Q2
FY2025 Q3$119,000
$119,000
Q3
FY2025 Q4$85.2M
$85.2M
Q4
Actual
+$85.2M (+230194.6%)

Net Income

$-140.1M
FY2024 Q1$-32.4M
$-32.4M
Q1
FY2024 Q2$-67.4M
$-67.4M
Q2
FY2024 Q3$-111.2M
$-111.2M
Q3
FY2024 Q4$-160.9M
$-160.9M
Q4
FY2025 Q1$-48M
$-48M
Q1
FY2025 Q2$-102.6M
$-102.6M
Q2
FY2025 Q3$-159.5M
$-159.5M
Q3
FY2025 Q4$-140.1M
$-140.1M
Q4
Actual
+$20.8M (+12.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$13.6M
Est:$15.2M
FY2020MISS
$13.6M
FY2021MISS
Actual:$18M
Est:$18.8M
FY2021MISS
$18M
FY2022BEAT
Actual:$3.1M
Est:$2.6M
FY2022BEAT
$3.1M
FY2023BEAT
Actual:$20.7M
Est:$20.2M
FY2023BEAT
$20.7M
FY2024MISS
Actual:$37,000
Est:$1.3M
FY2024MISS
$37,000
FY2025BEAT
Actual:$85.2M
Est:$33.5M
FY2025BEAT
$85.2M

Analyst Estimates